Technology

Public Health Software Pioneer Chexout Evolves into Aveva Public Health Solutions, Unveiling a Dynamic Rebranding Initiative

Published

2 years ago

June 26, 2024

Aveva’s Renaming Reflects Expanded Public Health Technology Offerings,
Signals Next Phase of Growth

VIENNA, Va., June 26, 2024 /PRNewswire/ — Chexout, a pioneering force in Public Health software solutions, proudly announces its transformation into Aveva Public Health Solutions (www.avevatech.com) (“Aveva”) effective immediately. This pivotal evolution is accompanied by an extensive rebranding initiative, aligning with the company’s 14-year legacy as an INC 5000 award-winning enterprise.

Joseph Paulini, CEO of Aveva Public Health Solutions, remarked, “Our transition to Aveva and the accompanying rebranding are natural progressions, driven by the evolving needs of our clientele, including state, city, county, and local health departments. This strategic shift underscores our commitment to innovation and our dedication to enhancing Public Health’s data collection needs.”

He added, “The imperative for modernizing Public Health infrastructure gained unprecedented urgency during the pandemic. The resultant Data Modernization Initiative catalyzed a paradigm shift, necessitating agile, interoperable solutions. Aveva stands at the forefront of this movement, empowering Public Health entities with robust technology tailored to their evolving demands.”

Aveva’s journey began in 2010 with a singular focus on serving Public Health agencies, particularly STD/HIV clinics at the state and local levels. Serendipitously, a comprehensive software overhaul, featuring advanced surveillance, investigative, contact tracing and data collection functionalities, preceded the onset of the COVID-19 crisis, catalyzing exponential growth for the company.

With an unwavering commitment to excellence, Aveva endeavors to deliver unparalleled Public Health technology solutions, optimizing operational efficiency and amplifying community health initiatives. Recent contracts with prominent state health departments and major metropolitan centers have galvanized Aveva’s expansion efforts, facilitating the diversification of product modules encompassing clinic management, electronic health records, field surveillance and investigations, immunization tracking, population health analytics, and vital records management.

To explore Aveva’s transformative vision for the future of Public Health Data System Modernization, visit avevatech.com. Experience the essence of Aveva’s new identity and brand narrative through the explanatory video available here.

About Aveva (formerly Chexout)

Aveva Public Health Solutions is a pioneering provider of secure, cloud-based, fully integrated IT solutions tailored exclusively for Public Health agencies. Our highly configurable data collection suite caters to diverse Public Health domains, including Clinics, WIC programs, Immunization programs, Population Health initiatives, Surveillance systems, Field Investigations, Emergency Health responses, Environmental health initiatives, and various Public Health programs wherever comprehensive data collection and program management capabilities are needed. Aveva empowers decision-makers with real-time actionable insights, facilitating informed strategies and fostering community well-being.

For a personalized demonstration of Aveva’s innovative solutions or to schedule an interview with CEO Joseph Paulini regarding the company’s rebranding and Public Health IT modernization initiatives, please contact info@avevatech.com.

Media Contact:

Nancy Rose Senich
Aveva Public Health Solutions
nsenich@avevatech.com
nancy@rose4results.com
1-202-262-6996 cell/text
http://avevatech.com

Follow Aveva: Linked In: http://linkedin.com/company/aveva-public-health-solutions | X: @AvevaTech

View original content to download multimedia:https://www.prnewswire.com/news-releases/public-health-software-pioneer-chexout-evolves-into-aveva-public-health-solutions-unveiling-a-dynamic-rebranding-initiative-302183353.html

SOURCE Chexout; Aveva Public Health Solutions

Technology

IGCS International Announces Strategic Equity Investment by Lacks Enterprises

Published

39 minutes ago

April 22, 2026

DALLAS, April 22, 2026 /PRNewswire/ — IGCS International, a CVE-certified SDVOSB and leading provider of mission support and MRO supplies to the U.S. Department of Defense and federal agencies, today announced that Lacks Enterprises has acquired an equity stake in the company.

The strategic investment combines IGCS’s expertise in government supply chain, logistics, and MRO solutions with Lacks Enterprises’ advanced manufacturing capabilities, including electroplating, injection molding, composites, and testing for aerospace and defense.

“IGCS has built a strong track record supporting the Department of Defense… Partnering with Lacks Enterprises allows us to integrate cutting-edge manufacturing innovation into our offerings,” said Russ Spears, President of IGCS International.

Media Contact: Russ Spears, 214-733-7278, russ@igcsintl.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/igcs-international-announces-strategic-equity-investment-by-lacks-enterprises-302750824.html

SOURCE IGCS International

Technology

Shoulder Innovations to Report First Quarter 2026 Financial Results on May 13, 2026

Published

39 minutes ago

April 22, 2026

GRAND RAPIDS, Mich., April 22, 2026 /PRNewswire/ — Shoulder Innovations, Inc. (“Shoulder Innovations”) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the first quarter of 2026 after market close on Wednesday, May 13, 2026.

Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on May 13, 2026. Those interested in listening to the conference call may do so by dialing (877) 407-8216 for domestic callers or (412) 902-1015 for international callers and providing access code 13759613. A live and archived webcast of the event will be available in the “Investor Relations” section of the Shoulder Innovations website at https://ir.shoulderinnovations.com/.

About Shoulder Innovations
Shoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, with a current offering of advanced implant systems for shoulder arthroplasty. These systems are a core element of Shoulder Innovations’ ecosystem, which is designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain. Shoulder Innovations’ ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration. Together, these elements seek to address the long-standing clinical and operational challenges in the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care.

Contact
Brian Johnston or Sam Bentzinger
Gilmartin Group LLC
ir@shoulderinnovations.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/shoulder-innovations-to-report-first-quarter-2026-financial-results-on-may-13-2026-302750154.html

SOURCE Shoulder Innovations

Technology

Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026

Published

39 minutes ago

April 22, 2026

MADISON, Wis., April 22, 2026 /PRNewswire/ — Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2026, ended March 31, 2026, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on May 6, 2026.

The conference call dial-in numbers are 1-833-316-0563 (USA) or 1-412-317-5747 (international). In addition, a dial-up replay of the conference call will be available approximately one hour after the call’s conclusion for one week. The replay number is 1-855-669-9658 (USA) or 1-412-317-0088 (international), conference ID: 4178502.

A live webcast of the call will also be available from the Investor Relations section of the company’s website at investors.accuray.com. A webcast replay can be accessed on the website and will remain available until Accuray announces its results for the fourth quarter of fiscal 2026.

About Accuray
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Madison, Wisconsin, with facilities worldwide. To learn more, visit www.accuray.com or follow us on Facebook, LinkedIn, X, and YouTube.

Investor and Media Contact
Steve Monroe
VP, Financial Planning & Analysis, Accuray
Investor.relations@accuray.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-to-report-third-quarter-fiscal-2026-financial-results-on-may-6-2026-302750641.html

SOURCE Accuray Incorporated